Overview
Gordonia, first described in 1997, comprises over 30 species of bacteria isolated from diverse habitats, including soil, aquatic systems, and industrial sites. Taxonomically, it belongs to the family Gordoniaceae and is closely related to Rhodococcus and Nocardia. These bacteria are distinguished by their high GC content, filamentous growth, and ability to metabolize complex organic compounds. Gordonia species are industrially significant due to their enzymatic versatility. They degrade pollutants like polycyclic aromatic hydrocarbons (PAHs) and synthetic rubber, making them valuable for bioremediation. Some strains also produce bioactive compounds with potential pharmaceutical applications.
Key Features
Gordonia exhibits unique physiological traits, including resistance to desiccation and UV radiation, enabling survival in harsh environments. Their cell walls contain mycolic acids, contributing to biofilm formation and adherence to hydrophobic substrates. Metabolically, they utilize alkanes, steroids, and xenobiotics as carbon sources. Notably, Gordonia spp. synthesize extracellular enzymes like dioxygenases and peroxidases, which break down persistent environmental contaminants. Strains such as G. polyisoprenivorans are studied for their ability to degrade tire rubber, offering solutions for waste management.
Application Areas
In environmental biotechnology, Gordonia is deployed for cleaning oil spills, treating industrial effluents, and reclaiming contaminated soils. Their hydrocarbon-degrading enzymes are harnessed in bioaugmentation strategies. For instance, G. alkanivorans degrades crude oil components efficiently. Beyond bioremediation, Gordonia produces trehalolipid biosurfactants used in cosmetics and antimicrobial agents. Research explores their role in synthesizing bioplastics and bioactive molecules, though industrial scaling remains a challenge. Medical studies investigate rare clinical infections linked to immunocompromised patients.
Precautions
While most Gordonia strains are non-pathogenic, species like G. bronchialis have been associated with pulmonary infections. Laboratories and industries handling these bacteria should adhere to Biosafety Level 2 (BSL-2) practices, including personal protective equipment (PPE) and proper waste disposal. Strain selection should prioritize non-pathogenic variants for field applications. Regulatory compliance, such as EPA guidelines for bioremediation agents, must be followed to ensure environmental and worker safety.
B2B Procurement Guide
For bioremediation projects, source strains from specialized culture collections (e.g., ATCC or DSMZ) with documented degradation profiles. Industrial suppliers may offer lyophilized or active cultures; verify viability and purity certificates. Pricing varies by strain and volume, ranging from approximately $200 to $1,000 per vial for research-grade samples. Bulk orders for field applications require customized quotes. Prioritize suppliers providing technical support for strain optimization and regulatory documentation.
Related Manufacturers
- 主营：科研试剂、高效试剂
- 主营：微生物菌种、标准菌株、益生菌、山东戈登氏菌、食用菌
- 主营：研突破、转座酶、重组酶、连接酶、研试剂、(5×)(with、recombinant、结合蛋白、胶体染料、核酸染料、助力科研、大肠杆菌、泛素蛋白、实验室用品、重组肠激酶、电泳缓冲液、拓扑异构酶、热敏磷酸酶、检测试剂盒、全能核酸酶、核酸外切酶、核酸内切酶、连接试剂盒、碱性磷酸酶、微球菌核酸酶